The McGill International TB Centre has Associate Members in other Institutions who participate regularly with Full Members of the Centre
Stéphanie Law, PhD
Department of Global Health and Social Medicine, Harvard Medical School
Stephanie Law, PhD, is an epidemiologist currently completing her postdoctoral training under Dr. Carole Mitnick at the Department of Global Health and Social Medicine, Harvard Medical School. Her research involves using qualitative and quantitative methods to explore the sociocultural aspects of tuberculosis care, with a particular focus on the role of trust between tuberculosis patients and their health care providers over the course of treatment. Her current research projects, spanning different topics in tuberculosis treatment and care, include collaborations with the McGill International TB Centre, the WHO and the Centre for the AIDS programme of Research in South Africa (CAPRISA). Dr. Law received her MSc and PhD degrees in epidemiology from McGill University, as well as her Master of Journalism degree from the University of British Columbia.
Luis Barreiro, PhD.
University of Chicago
Click here for more information
Luis Barreiro’s research focuses on a better understanding how natural selection has contributed to the evolution of our species and the extent to which past selection events impact present-day susceptibility to disease. Humans and our close evolutionary relatives respond differently to a large number of infections. While AIDS, malaria, and cancer kill millions of humans around the world every year, several non-human primates appear to be naturally protected against these diseases. Such differences between humans and other primates are thought to be the result, at least in part, of inter-species differences in immune response to infection. However, due to the lack of comparative functional data across species, the ways in which the immune systems of humans and other primates differ remain unclear. In the laboratory, we are studying the phenotypic evolution of immune responses in primates by combining in-vitro immunological assays with cutting-edge genomic techniques. Our projects promise to identify inter-species differences in early response to infection that may explain differences in susceptibility to diseases among primates
Dr. Anurag Bhargava, M.D.(Medicine), M.Sc.(Epidemiology)
Professor, Department of Medicine
Adjunct Professor in the Department of Medicine at McGill
Yenepoya Medical College
District of Dakshin Kannada (South Canara), Karnataka, India
Email: anuragb17 [at] gmail.com
Anurag Bhargava is currently a Professor in the department of Internal Medicine at Yenepoya Medical College, Mangalore and also associated with the Center for Nutrition Studies, Yenepoya University. He has worked on the interface of clinical medicine and public health in diverse settings across India, including as a rural physician for 10 years. He serves on advisory committees for organisations like the National TB Elimination Programme, WHO SEAR, WHO Geneva. He too has been involved in the RATIONS trial for the past 3 years.
Claudia Denkinger, PhD
Head of Division of Tropical Medicine
University Hospital Heidelberg
Claudia.denkinger [at] uni-heidelberg.de
Mobile: +49 6221 56-36637
Claudia completed her medical school training, PhD thesis in immunology and Master in Tropical Medicine and International Public Health at the Julius-Maximilians University, Würzburg, Germany, Case Western Reserve University, Cleveland, USA and the London School of Hygiene and Tropical Medicine, UK. Her postdoctoral fellowship at McGill University, Montreal, Canada, focused on tuberculosis epidemiology and impact assessment as well as mathematical modelling of tuberculosis diagnostics. Claudia specialised in internal medicine and infectious disease at the Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School, USA and was also a chief medical resident there. She has worked in non-governmental organizations in HIV and tuberculosis care in South Africa and South America. Most her of research has focused on tuberculosis diagnostics development and clinical trialling. The last five years she has lead the tuberculosis program at the Foundation of Innovative New Diagnostics (FIND) and has also established a new hepatitis program. For her work on tuberculosis diagnostics, Claudia has been given the Gertrud Meissner Award of the European Society of Mycobacteriology in 2016.
Dr. Nora Engel, PhD.
Assistant Professor, Global Health
n.engel [at] maastrichtuniversity.nl
Nora Engel is assistant professor global health at Maastricht University. She is a social scientist with a particular interest in how new technologies and interventions for global health challenges (such as tuberculosis) are being envisioned, developed, implemented and evaluated and uses Science and Technology Studies to make sense of these innovation dynamics theoretically. She has done extensive qualitative fieldwork in India and South Africa as well as in the global health policy arena, among others on innovation in TB control and policy, challenges to point of care testing, evaluation of mobile health solutions and innovation processes of point-of-care diagnostics for TB and HIV. Some of this work has been done in collaboration with Madhukar Pai and Nitika Pant Pai. She is a contributor on qualitative research to McGill’s Summer Institute since 2012 and together with Amrita Daftary successfully launched the qualitative methods course in 2017.
Dr. Greg Fox, PhD MMBS FRACP MBBS MIPH
CJ Martin Fellow
Greg Fox is Professor of Respiratory Medicine at the University of Sydney and Director of the Sydney Vietnam Institute. He is an international clinical trialist and epidemiologist whose research focuses upon tuberculosis (TB) and chronic lung disease. He holds an NHMRC Leadership fellowship. Over the past decade, he has established a research group in Vietnam which has conducted multicentre studies into the prevention and detection of TB in resource-limited settings. His research, in combination with evidence reviews for the World Health Organisation, have contributed to changes in global TB policies and clinical practice. Professor Fox works clinically as a Respiratory Physician at Sydney’s Royal Prince Alfred Hospital, is Area Director for Tuberculosis Services for Sydney Local Health District. He is committed to building research capacity in Australia and internationally.
The University of Sydney, Sydney Medical School - Central
Rm 574, Blackburn Building D06 | The University of Sydney | NSW | Australia 2006
T +61 2 9036 7028 | M +61 (0) 412 912 538 | Email: greg.fox [at] sydney.edu.au
Dr. Srinath Satyanarayana, MBBS, MD (Community Medicine), PhD (Epidemiology)
Deputy Director (Research),
Center for Operational Research,
International Union against Tuberculosis and Lung Disease (The Union)
New Delhi, India| E-Mail: drsrinaths [at] gmail.com; ssrinath [at] theunion.org
Dr. Anete Trajman, MD, PhD
Full Professor at the Federal University of Rio de Janeiro, Brazil and Adjunct (visiting) Professor at McGill University. Officer of the TB Section of the International Union of Tuberculosis and Lung Diseases 2017-2021. Member of the Advisory Board of the Brazilian National Tuberculosis Programme. Researcher (grantee) of the Brazilian Ministry of Science and Technology. Member of the Reviewers College of the Canadian Institute of Health Research. Associate Editor for BMC Health Services research, Plos One and Plos Global Health. Former president of the Brazilian TB Research Network (Rede-TB), currently coordinator of the Clinical Research Department of Rede-TB.
Rio de Janeiro, Brazil | atrajman [at] gmail.com (E-Mail) | Google scholar
Toyin Togun, MD, MPH, PhD
Associate Professor and Co-Director of the TB Centre, London School of Hygiene and Tropical Medicine (LSHTM), and
Clinician-Scientist in the Vaccines & Immunity Theme, MRC Unit The Gambia at LSHTM
Telephone +44 (0) 20 7927 2380, Email: Toyin.Togun [at] lshtm.ac.uk
Focus: Global health and implementation research that is focused on the discovery and practical applications of new tools and strategies to improve the diagnosis and management of childhood tuberculosis (TB) in high burden settings.
Keywords: Childhood tuberculosis, Diagnostics, Biosignatures, Sub-Sahara Africa
Follow on PubMed
Rovina Ruslami, MD, PhD
Professor of Pharmacology
Rovina is an academic staff of Faculty of Medicine, Universitas Padjadjaran (UNPAD), Bandung, Indonesia, since 1997. She is now head of Department of Biomedical Science with 7 divisions, including pharmacology. At the teaching hospital (Hasan Sadikin General Hospital) Bandung, head of Department of Clinical Pharmacology; my teaching focused on pharmacology, clinical pharmacology, research ethics, and research methodology.
(2020 – 2022) was also the head of the Indonesia TB Research Network, called as "JetSet (Jejaring Riset = research network) TB Indonesia", and is acting as principal investigator for several international studies. Since 2018 has been working voluntarily for the International Union Against Tuberculosis and Lung Disease (The Union) as the scientific liaison for the TB Section and starting 2021 as the Tuberculosis Conference Programme Lead.